Abstract
Compounds containing 2-arybenzimidazole ring systems linked to arylpiperidines were synthesized and evaluated as MCH-R1 antagonists. The results of structure-activity relationship studies led to the identification of compound 4c as a potent MCH-R1 antagonist (IC(50)=1 nM). This compound also has good metabolic stability, and favorable pharmacokinetic and brain penetration properties. However 4c was found to be potent inhibitor of the hERG potassium channel.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetanilides / chemical synthesis*
-
Acetanilides / chemistry
-
Acetanilides / pharmacokinetics
-
Administration, Oral
-
Animals
-
Benzimidazoles / chemical synthesis*
-
Benzimidazoles / chemistry
-
Benzimidazoles / pharmacokinetics
-
Brain / metabolism
-
Humans
-
Rats
-
Receptors, Somatostatin / antagonists & inhibitors*
-
Receptors, Somatostatin / metabolism
-
Structure-Activity Relationship
Substances
-
Acetanilides
-
Benzimidazoles
-
MCHR1 protein, human
-
Receptors, Somatostatin